…
FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. The Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents. Its Electronic segment provides display and touch panel, semiconductor and image sensors, and functional film materials; storage media and archiving services; semiconductor and display materials; industrial equipment; and fine chemicals. The Business Innovation segment offers office equipment, including multi-function devices and printers; problem-solving document services tailored to diverse business formats and roles, including system integration, cloud service, business process outsourcing, and others; equipment and materials for graphic communications; and inks and industrial inkjet printheads. Its Imaging segment provides color films, instant cameras, developing and printing systems, color papers, and photo printing services; TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors; instant photo systems; services for photofinishing; digital cameras; and optical devices. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Minato, Japan.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Fujifilm Holdings is a diversified Japanese multinational supplying imaging, healthcare, life-science and industrial materials and services. Long-term growth drivers include expansion in healthcare and pharmaceuticals, demand for data storage and medical imaging, and higher-value industrial material applications that may support margin improvement. Investors may find the company attractive for its diversified revenue mix and established R&D and manufacturing capabilities.
Key investment risks include secular decline in consumer/office imaging, competition and technological change in storage and healthcare, and regulatory and pricing pressure in pharmaceuticals.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 339274.00M | 321399.00M | 282224.00M | 260446.00M | 235870.00M |
| Minority interest | -728.00M | 212.00M | -2252.00M | -5265.00M | 17591.00M |
| Net income | 260951.00M | 243509.00M | 211180.00M | 181205.00M | 181205.00M |
| Selling general administrative | 806525.00M | 752427.00M | 710702.00M | 652995.00M | 552068.00M |
| Gross profit | 1300079.00M | 1186260.00M | 1137928.00M | 1033224.00M | 869691.00M |
| Reconciled depreciation | 163567.00M | 150014.00M | 142215.00M | 132999.00M | 123423.00M |
| Ebit | 349346.00M | 325771.00M | 287892.00M | 258309.00M | 189670.00M |
| Ebitda | 512913.00M | 475785.00M | 430107.00M | 391308.00M | 313093.00M |
| Depreciation and amortization | 163567.00M | 150014.00M | 142215.00M | 132999.00M | 123423.00M |
| Operating income | 330155.00M | 276725.00M | 273079.00M | 229702.00M | 165473.00M |
| Other operating expenses | 2865673.00M | 2684191.00M | 2585962.00M | 2296071.00M | 2027046.00M |
| Interest expense | 8752.00M | 8483.00M | 5006.00M | 2316.00M | 2578.00M |
| Tax provision | 77595.00M | 78102.00M | 65206.00M | 57129.00M | 55611.00M |
| Interest income | 13380.00M | 12226.00M | 7670.00M | 4646.00M | 3884.00M |
| Net interest income | 4628.00M | 3743.00M | 2664.00M | 2330.00M | 1306.00M |
| Income tax expense | 77595.00M | 78102.00M | 65206.00M | 57129.00M | 55611.00M |
| Total revenue | 3195828.00M | 2960916.00M | 2859041.00M | 2525773.00M | 2192519.00M |
| Total operating expenses | 969924.00M | 909535.00M | 864849.00M | 803522.00M | 704218.00M |
| Cost of revenue | 1895749.00M | 1774656.00M | 1721113.00M | 1492549.00M | 1322828.00M |
| Total other income expense net | 9119.00M | 44674.00M | 13801.00M | 43872.00M | 73595.00M |
| Net income from continuing ops | 261679.00M | 243297.00M | 221674.00M | 216445.00M | 183457.00M |
| Net income applicable to common shares | - | - | 219307.00M | 211180.00M | 181205.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 5249908.00M | 4783460.00M | 4134311.00M | 3955280.00M | 3549203.00M |
| Intangible assets | 1105471.00M | 320315.00M | 1002569.00M | 976694.00M | 932695.00M |
| Other current assets | 198429.00M | 189773.00M | - | 733934.00M | 694919.00M |
| Total liab | 1897226.00M | 1610145.00M | 1346451.00M | 1430340.00M | 1327046.00M |
| Total stockholder equity | 3348480.00M | 3169247.00M | 2763145.00M | 2502657.00M | 2204566.00M |
| Other current liab | 567192.00M | 505450.00M | 158766.00M | 196520.00M | 161651.00M |
| Common stock | 40363.00M | 40363.00M | 40363.00M | 40363.00M | 40363.00M |
| Capital stock | 40363.00M | 40363.00M | 40363.00M | 40363.00M | 40363.00M |
| Retained earnings | 2930151.00M | 2741416.00M | 2616191.00M | 2867848.00M | 2702760.00M |
| Other liab | - | - | - | 146798.00M | 116465.00M |
| Good will | 947924.00M | 953835.00M | 858311.00M | 824003.00M | 804199.00M |
| Other assets | - | - | - | 24210.00M | 33179.00M |
| Cash | 172111.00M | 179715.00M | 268608.00M | 486328.00M | 394795.00M |
| Total current liabilities | 1125940.00M | 1165841.00M | 890322.00M | 979575.00M | 716284.00M |
| Current deferred revenue | - | 47947.00M | 274023.00M | 248283.00M | 222046.00M |
| Net debt | 630174.00M | 427916.00M | 268292.00M | 102492.00M | 214781.00M |
| Short term debt | 246685.00M | 349692.00M | 211440.00M | 284853.00M | 115279.00M |
| Short long term debt | 215103.00M | 400829.00M | 180409.00M | 253359.00M | 303649.00M |
| Short long term debt total | 802285.00M | 607631.00M | 536900.00M | 588820.00M | 609576.00M |
| Other stockholder equity | 377966.00M | -56151.00M | -2656554.00M | -2908211.00M | -2743123.00M |
| Property plant equipment | - | - | - | 820228.00M | 713454.00M |
| Total current assets | 1581681.00M | 1574628.00M | 1631107.00M | 1724729.00M | 1507376.00M |
| Net tangible assets | - | - | - | 1442199.00M | 1205994.00M |
| Short term investments | - | -192161.00M | -183713.00M | -176859.00M | -153123.00M |
| Net receivables | 667165.00M | 657337.00M | 608645.00M | 598634.00M | 605718.00M |
| Long term debt | 470805.00M | 185716.00M | 270060.00M | 247101.00M | 439351.00M |
| Inventory | 543976.00M | 547803.00M | 567302.00M | 504467.00M | 417662.00M |
| Accounts payable | 279362.00M | 262752.00M | 246093.00M | 249919.00M | 217308.00M |
| Accumulated other comprehensive income | - | 443619.00M | - | - | - |
| Non currrent assets other | 509827.00M | 38815.00M | 114744.00M | 83764.00M | 65877.00M |
| Non current assets total | 3668227.00M | 3208832.00M | 2503204.00M | 2230551.00M | 2041827.00M |
| Capital lease obligations | 116377.00M | 104812.00M | 86431.00M | 88360.00M | 83884.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -541953.00M | -527416.00M | -323225.00M | 6841.00M | 18519.00M |
| Change to liabilities | - | - | - | 58315.00M | -2075.00M |
| Total cashflows from investing activities | -541953.00M | -527416.00M | - | -153542.00M | -279381.00M |
| Net borrowings | 181055.00M | 124501.00M | - | -57486.00M | -125202.00M |
| Total cash from financing activities | 108883.00M | -462.00M | -123695.00M | -105184.00M | -163093.00M |
| Change to operating activities | - | - | - | -33646.00M | 137614.00M |
| Net income | 261679.00M | 243509.00M | 221674.00M | 216445.00M | 183457.00M |
| Change in cash | -7604.00M | -88893.00M | -217720.00M | 91533.00M | -1296.00M |
| Begin period cash flow | 179715.00M | 268608.00M | 486328.00M | 394795.00M | 396091.00M |
| End period cash flow | 172111.00M | 179715.00M | 268608.00M | 486328.00M | 394795.00M |
| Total cash from operating activities | 428162.00M | 407941.00M | 210452.00M | 323934.00M | 420861.00M |
| Depreciation | 163567.00M | 150014.00M | 142215.00M | 132999.00M | 123423.00M |
| Other cashflows from investing activities | -43784.00M | -31333.00M | - | 5524.00M | -187000.00M |
| Dividends paid | 68252.00M | 56170.00M | -46109.00M | -43032.00M | -37975.00M |
| Change to inventory | -310.00M | 62023.00M | -51545.00M | -68273.00M | 9215.00M |
| Change to account receivables | -5348.00M | -21157.00M | -17052.00M | 34741.00M | 20576.00M |
| Sale purchase of stock | -16.00M | -31.00M | -20.00M | -31.00M | -20.00M |
| Other cashflows from financing activities | -3904.00M | -68762.00M | -3286.00M | -3852.00M | 1418.00M |
| Change to netincome | - | - | - | -16647.00M | -51349.00M |
| Capital expenditures | 558005.00M | 464712.00M | 323472.00M | 165907.00M | 125607.00M |
| Change in working capital | 23544.00M | 41099.00M | -143879.00M | -14497.00M | 130248.00M |
| Other non cash items | -20628.00M | -26681.00M | -9558.00M | -11013.00M | -16267.00M |
| Free cash flow | -129843.00M | -56771.00M | -113020.00M | 158027.00M | 295254.00M |
Sector: Industrials Industry: Conglomerates
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| FUJIY FUJIFILM Holdings Corp |
0.20 1.85% |
11.02 | 13.51 | 13.21 | 0.01 | 0.99 | 1.42 | 8.63 |
| MTSUY Mitsubishi Corporation |
0.08 0.24% |
33.30 | 23.01 | 15.60 | 0.01 | 1.91 | 1.18 | 13.36 |
| MSBHF Mitsubishi Corp. |
0.46 1.41% |
33.14 | 22.90 | 15.90 | 0.01 | 1.94 | 1.18 | 13.36 |
| ITOCF ITOCHU Corporation |
- -% |
14.45 | 18.13 | 16.50 | 0.01 | 2.45 | 1.37 | 11.52 |
| MITSY Mitsui & Company Ltd |
9.92 1.59% |
632.72 | 17.30 | 15.77 | 0.01 | 1.62 | 1.30 | 11.28 |
FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. The Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents. Its Electronic segment provides display and touch panel, semiconductor and image sensors, and functional film materials; storage media and archiving services; semiconductor and display materials; industrial equipment; and fine chemicals. The Business Innovation segment offers office equipment, including multi-function devices and printers; problem-solving document services tailored to diverse business formats and roles, including system integration, cloud service, business process outsourcing, and others; equipment and materials for graphic communications; and inks and industrial inkjet printheads. Its Imaging segment provides color films, instant cameras, developing and printing systems, color papers, and photo printing services; TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors; instant photo systems; services for photofinishing; digital cameras; and optical devices. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Minato, Japan.
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenji Sukeno | Exec. Chairman of The Board | 1954 |
| Mr. Teiichi Goto | Pres, CEO & Director | 1959 |
| Mr. Takashi Iwasaki | Corp. VP, CTO & Director | 1956 |
| Mr. Shigetaka Komori | Exec. Advisor | 1940 |
| Mr. Masayuki Higuchi | Corp. VP, GM of Corp. Planning Division, CFO & Director | 1963 |
| Ms. Chisato Yoshizawa | Corp. VP, GM of Corp. Communications and ESG Division & Director | 1963 |
| Yasushi Zama | Director, Corp. VP & GM of HR Division | NA |
| Kazuhisa Horikiri | Corp. VP, GM of Design Strategy Office & Brand Management | NA |
| Seigo Sugimoto | Corp. VP, Chief Digital Officer & GM of ICT Strategy Office | NA |
| Shuzo Takada | Corp. VP, GM of Gov. Relations Div & Deputy Gen. Mang. of CTO Office | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.